Calibr

Return to Grants

Total Awards:

3

Award Value:

$12,422,058

Institution type:

Not for profit

Short Name:

Calibr

Awards to the Institution

Program Type	Investigator	Grant Title	Award Value
Clinical Trial Stage Projects	Dr. Kristen A Johnson	Evaluation of the Safety and Tolerability of KA34 in a Phase 1, Double-Blind, Dose Escalation Trial in Patients with Knee Osteoarthritis	$8,447,523
Late Stage Preclinical Projects	Peter G Schultz	Development of a Chondrogenic Drug Candidate Targeting Resident Mesenchymal Stem Cells for the Treatment of Osteoarthritis	$1,667,832
Preclinical Development Awards	Peter G Schultz	Development of a Chondrogenic Drug Candidate Targeting Cartilage-residing Mesenchymal Stem Cells for the Treatment of Osteoarthritis	$2,306,703
			Total: $12,422,058.00

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.